ENDO 2024 Call for Abstracts

November 30, 2023

Taking place in person in Boston, MA, June 1-4, there is no better place to share your research than ENDO. Submitting an abstract earns media coverage for your work, connects you with scientific investigators with similar interests, and helps drive patient care for the people that need us most. All accepted abstracts will also be published in a supplement to our Open Access publication, Journal of the Endocrine Society (JES) and assigned a DOI. Outstanding abstracts submitted by in-training fellows and new faculty are also eligible for abstract awards. Submit your abstract by Tuesday, January 9, 2024 to take advantage of this opportunity to share your work with our field!


  • Access the abstract submission site to begin your submission, edit a current submission, and to print confirmations and receipts for completed submissions.
  • The abstract character limit is 2,500 characters, including punctuation and symbols, but not spaces.
  • You must have an endocrine.org user account to submit an abstract. Sign in or create an account.

Review the Abstract Submission Guidelines and the Abstract Submission Instructions prior to submitting your abstract.  If you have any questions regarding your submission, contact [email protected].  

  • There will be no options for virtual participation at ENDO 2024.  The annual meeting will be fully in-person. 
  • Abstract submission does not automatically register you for ENDO. Presenting authors must be registered for your abstract to be included in the ENDO 2024 program.
  • All submissions require payment of the non-refundable $90 abstract handling fee.
  • Receipts for the non-refundable $90 abstract handling fee are available within the abstract submission site. To access, log in with your endocrine.org username and password. 
  • Submitting authors may log into the site to edit their abstract up until the abstract submission deadline. NO REVISIONS to the abstract or the list of authors will be allowed once the site closes on the deadline date. 
  • Late-breaking abstracts will be accepted March 19 – April 10.

ENDO 2024 Abstract Embargo Policy

Unless otherwise noted, all abstracts presented at ENDO must not be released to the press or the public until the date and time of presentation. For oral presentations, the abstracts are embargoed until the session begins. Abstracts presented at a news conference are embargoed until the date and time of the news conference. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO. Please visit the ENDO media resource page for more information.

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.